Aurisco Pharmaceutical Co., Ltd. (605116)
Market Closed
10 Aug, 06:57
SSE SSE Primary ¥
20. 45
-0.1
-0.4866%
¥
8.16B Market Cap
- P/E Ratio
0.88% Div Yield
3.23M Volume
- Eps
¥ 20.55
Previous Close Want to track 605116 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Aurisco Pharmaceutical Co., Ltd. (605116) Statistics
Valuation metrics
Market Cap 8.16B
Enterprise value 8.63B
Trailing P/E (ttm) 21.41
Forward P/E -
PEG ratio -7.06
Price/Sales (ttm) 4.95
Price/Book (mrq) 3.02
Enterprise Value/Revenue 5.12
Enterprise Value/EBITDA 15.09
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 3.13M
Average volume (90 days) 3.69M
Price summary
52-Week low 18.09
52-Week high 35.58
Beta -
50-Day moving average 19.73
200-Day moving average 23.52
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.34
Trailing annual dividend yield 0.0165%
5-Year annual dividend yield -
Payout ratio 0.31
Dividend Date 15 Jun 2026
Ex-Dividend Date 15 Jun 2026
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.23%
Operating margin 0.28%
Operational effectiveness
Return on assets 0.09%
Return on equity 0.15%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 4.22
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.99
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.3
Total debt (mrq) -
Total Debt/Equity (mrq) 0.36
Current ratio (mrq) 4.22%
Book value per share (mrq) 6.8
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
